The way you used to establish cardiac function is going to change
The way you used to establish cardiac function is going to change
Medis has been developing software solutions to support the healthcare professionals in their CT, MRI, X-Ray and Ultrasound procedures for over thirty years. Medis multi-modality software is best in class and vendor independent, it can be used in both scientific research and in clinical routine.
QFR is proven by >150 peer-reviewed papers, including >14.000 patients and >17.000 vessels.
FAVOR III China outcome trial proved that the QFR-guided group had a 34% relative risk reduction in 1-year MACE, compared with the angio-guided group.
FAVOR III EU outcome study is progressing well in Europe.
On a daily basis, our product and support teams are in contact with our customers. Our specialists are assisting our customers for them to use the software of Medis to
Medis presents: a series of 11 interviews with QFR® KOL’s During the EuroPCR 2022 in Paris we have had the opportunity to engage in many interesting conversations with various QFR®
The PCR-EAPCI Percutaneous Interventional Cardiovascular Medicine Textbook is a first-of-its-kind, all-inclusive reference whose scope and content are patient-centered and promote good, evidence-based clinical practices. The essential reference book for all
To be the first informed about our latest news.
Medis Medical Imaging Systems BV
Schuttersveld 9, 2316 XG Leiden
P.O. Box 384, 2300 AJ Leiden, The Netherlands
©2022 Medis Medical Imaging Systems B.V. All rights reserved.
Last updated: 04-07-2022
